Feed Preview

Vitamin K Carboxylase & Antibiotics

Vitamin K Carboxylase & Antibiotics diagram by

Vitamin K-dependent carboxylases generate gamma-carboxyglutamic acids with malonate moieties by modifying glutamate residues in vitamin K-dependent proteins. This feed focuses on cellular mechanisms regulated by vitamin K-dependent carboxylases.

Top 20 most recent papers
Antimicrobial Agents and Chemotherapy

Characterization of FosL1, a plasmid-encoded fosfomycin resistance protein identified in Escherichia coli

Antimicrobial Agents and ChemotherapyJanuary 15, 2020
Nicolas KiefferPatrice Nordmann
Antimicrobial Agents and Chemotherapy

First occurrence of the OXA-198 carbapenemase in Enterobacterales

Antimicrobial Agents and ChemotherapyJanuary 15, 2020
Rémy A BonninThierry Naas
Antimicrobial Agents and Chemotherapy

Distinct Subpopulations of Intravalvular Methicillin-Resistant Staphylococcus aureus With Variable Susceptibility to Daptomycin in Tricuspid Valve Endocarditis

Antimicrobial Agents and ChemotherapyJanuary 15, 2020
Christopher R MillerAndrew D Berti
1
Protein Science : a Publication of the Protein Society

Allosteric inhibitors of Mycobacterium tuberculosis tryptophan synthase

Protein Science : a Publication of the Protein SocietyJanuary 14, 2020
Karolina MichalskaAndrzej Joachimiak
1
bioRxiv

Role of DNA Methylation in Persister Formation in Uropathogenic E. coli

bioRxivJanuary 8, 2020
Yuanyuan XuYing Zhang
10
Antimicrobial Agents and Chemotherapy

Safety, tolerability, pharmacokinetics and antimalarial activity of the novel Plasmodium phosphatidylinositol 4-kinase inhibitor MMV390048 in healthy volunteers

Antimicrobial Agents and ChemotherapyJanuary 15, 2020
Phumla SinxadiKaren I Barnes
Antimicrobial Agents and Chemotherapy

CORRELATION OF LINEZOLID HAIR CONCENTRATIONS WITH PLASMA EXPOSURE IN PATIENTS WITH DRUG-RESISTANT TB

Antimicrobial Agents and ChemotherapyJanuary 15, 2020
Sean WassermanJohn Metcalfe
Antimicrobial Agents and Chemotherapy

Relationship between Vancomycin Minimum Inhibitory Concentration with Virulence Genes Expression and Clonal Complexes of Methicillin-Susceptible Staphylococcus aureus (MSSA) Strains Isolated from Left-sided Endocarditis

Antimicrobial Agents and ChemotherapyJanuary 8, 2020
Juan M PericàsHospital Clinic Endocarditis Study Group
6
Antimicrobial Agents and Chemotherapy

Population Pharmacokinetics of Teicoplanin in Preterm and Term Neonates: is it Time for a New Dosing Regimen?

Antimicrobial Agents and ChemotherapyJanuary 15, 2020
A KontouE Roilides
Antimicrobial Agents and Chemotherapy

Real-world experience with ceftolozane-tazobactam for multidrug-resistant gram-negative bacterial infections

Antimicrobial Agents and ChemotherapyJanuary 15, 2020
Sarah C J JorgensenMichael J Rybak
5
Antimicrobial Agents and Chemotherapy

Minocycline-EDTA-Ethanol Antimicrobial Catheter Lock Solution is highly effective in vitro for Eradication of Candida auris Biofilms

Antimicrobial Agents and ChemotherapyJanuary 15, 2020
Ruth A ReitzelIssam I Raad
7
1
Antimicrobial Agents and Chemotherapy

Suppression of β-Lactam Resistance by Aspergillomarasmine A is Influenced by Both the Metallo-β-Lactamase Target and the Antibiotic Partner

Antimicrobial Agents and ChemotherapyJanuary 15, 2020
Caitlyn M RotondoGerard D Wright
4
Antimicrobial Agents and Chemotherapy

Mechanisms of acquired in vivo and in vitro resistance to voriconazole by Candida krusei following exposure to suboptimal drug concentration

Antimicrobial Agents and ChemotherapyJanuary 15, 2020
Elisabete RicardoCidália Pina-Vaz
6
Antimicrobial Agents and Chemotherapy

Dalbavancin and wound healing: new evidences/insights in a mouse model of skin infection

Antimicrobial Agents and ChemotherapyJanuary 15, 2020
Oriana SimonettiOscar Cirioni
Antimicrobial Agents and Chemotherapy

In vitro Evaluation of Antifungal Drug Combinations against Multidrug-resistant Candida auris isolates from New York Outbreak

Antimicrobial Agents and ChemotherapyJanuary 15, 2020
Brittany O'BrienVishnu Chaturvedi
25
Antimicrobial Agents and Chemotherapy

Antimalarial drug resistance profiling of Plasmodium falciparum infections in Ghana using molecular inversion probes and next generation sequencing

Antimicrobial Agents and ChemotherapyJanuary 15, 2020
Benedicta A MensahAnita Ghansah
Antimicrobial Agents and Chemotherapy

Drug development against smallpox: present and future

Antimicrobial Agents and ChemotherapyJanuary 15, 2020
Déborah Delaune, Frederic Iseni
2
Antimicrobial Agents and Chemotherapy

Evaluating accuracy of microsatellite markers for classification of recurrent infections during routine monitoring of anti-malarial drug efficacy: A computer modelling approach

Antimicrobial Agents and ChemotherapyJanuary 15, 2020
Sam JonesIan M Hastings
Antimicrobial Agents and Chemotherapy

Tryptophan trimers and tetramers inhibit dengue and Zika virus replication by interfering with viral attachment processes

Antimicrobial Agents and ChemotherapyJanuary 15, 2020
Antonios FikatasDominique Schols
1
Antimicrobial Agents and Chemotherapy

Sub-Inhibitory Concentrations of Mupirocin Stimulate Staphylococcus aureus Biofilm Formation by Up-regulating cidA

Antimicrobial Agents and ChemotherapyJanuary 15, 2020
Ye JinFangyou Yu

See more papers from this feed

Related Feeds

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS therapies here.

ATP Synthases

ATP synthases are enzymes located in the inner mitochondrial membrane that catalyze the synthesis of ATP during cellular respiration. Discover the latest research on ATP synthases here.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Anthelmintics

Anthelmintics or antihelminthics are a group of antiparasitic drugs that expel parasitic worms (helminths) and other internal parasites from the body by either stunning or killing them and without causing significant damage to the host. Discover the latest research on anthelmintics here.

Anthrax

Anthrax toxin, comprising protective antigen, lethal factor, and oedema factor, is the major virulence factor of Bacillus anthracis, an agent that causes high mortality in humans and animals. Here is the latest research on Anthrax.

Anthrax Vaccines

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.

Antianginal Drugs: Mechanisms of Action

Antianginal drugs, including nitrates, beta-blockers, and calcium channel blockers, are used in the treatment of angina pectoris. Here is the latest research on their use and their mechanism of action.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.

© 2020 Meta ULC. All rights reserved
/feed-previews/vitamin-k-carboxylase-antibiotics/fea59940-c142-4c78-a1d9-e41371224369